NO863386L - Analogifremgangsmaate for fremstilling av komplekser av visse cardiotoniske fosfodiesterase-inhibitorer og vannopploeselige vitaminer. - Google Patents

Analogifremgangsmaate for fremstilling av komplekser av visse cardiotoniske fosfodiesterase-inhibitorer og vannopploeselige vitaminer. Download PDF

Info

Publication number
NO863386L
NO863386L NO863386A NO863386A NO863386L NO 863386 L NO863386 L NO 863386L NO 863386 A NO863386 A NO 863386A NO 863386 A NO863386 A NO 863386A NO 863386 L NO863386 L NO 863386L
Authority
NO
Norway
Prior art keywords
carbon atoms
alkyl
acid
complex
hydrogen
Prior art date
Application number
NO863386A
Other languages
English (en)
Norwegian (no)
Other versions
NO863386D0 (no
Inventor
Eric J Benjamin
Gary C Visor
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO863386D0 publication Critical patent/NO863386D0/no
Publication of NO863386L publication Critical patent/NO863386L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO863386A 1985-08-23 1986-08-22 Analogifremgangsmaate for fremstilling av komplekser av visse cardiotoniske fosfodiesterase-inhibitorer og vannopploeselige vitaminer. NO863386L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76854985A 1985-08-23 1985-08-23

Publications (2)

Publication Number Publication Date
NO863386D0 NO863386D0 (no) 1986-08-22
NO863386L true NO863386L (no) 1987-02-24

Family

ID=25082816

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863386A NO863386L (no) 1985-08-23 1986-08-22 Analogifremgangsmaate for fremstilling av komplekser av visse cardiotoniske fosfodiesterase-inhibitorer og vannopploeselige vitaminer.

Country Status (11)

Country Link
EP (1) EP0212647A3 (da)
JP (1) JPS6284022A (da)
AU (1) AU595826B2 (da)
DK (1) DK403086A (da)
ES (1) ES2001114A6 (da)
FI (1) FI863404A7 (da)
HU (1) HU198395B (da)
IL (1) IL79815A (da)
NO (1) NO863386L (da)
NZ (1) NZ217324A (da)
ZA (1) ZA866388B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0523513A1 (de) 1991-07-05 1993-01-20 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung substituierter Pyridazine zur Behandlung von Dermatosen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189492A (en) * 1977-05-31 1980-02-19 Richardson-Merrell Inc. Antihypertensive compositions of 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole and N-(2-chloroethyl)-N-(1-methyl-2-phenoxy-ethyl)benzenemethanamine
EP0011828A1 (en) * 1978-11-23 1980-06-11 The Wellcome Foundation Limited Pharmaceutical combinations including hydantoin derivatives, pharmaceutical formulations containing the combinations and methods of making the formulations

Also Published As

Publication number Publication date
HUT41639A (en) 1987-05-28
IL79815A (en) 1990-07-12
ES2001114A6 (es) 1988-04-16
EP0212647A3 (en) 1989-07-19
NZ217324A (en) 1988-06-30
IL79815A0 (en) 1986-11-30
EP0212647A2 (en) 1987-03-04
DK403086A (da) 1987-02-24
FI863404L (fi) 1987-02-24
AU6174686A (en) 1987-02-26
DK403086D0 (da) 1986-08-22
FI863404A0 (fi) 1986-08-22
AU595826B2 (en) 1990-04-12
ZA866388B (en) 1988-04-27
FI863404A7 (fi) 1987-02-24
NO863386D0 (no) 1986-08-22
HU198395B (en) 1989-10-30
JPS6284022A (ja) 1987-04-17

Similar Documents

Publication Publication Date Title
US4837239A (en) Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
CN110698415B (zh) 一种肌球蛋白抑制剂及其制备方法和用途
US10150779B2 (en) Aldose reductase inhibitors and methods of use thereof
US12527763B2 (en) Pyrrole amide compound and use thereof
EP3192796A1 (en) Aldose reductase inhibitors and uses thereof
US20210179632A1 (en) Thienopiperidine derivative and use thereof
WO2014113380A1 (en) Aldose reductase inhibitors and uses thereof
US20110245207A1 (en) Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations
CN106632245B (zh) 氮取代基苯基吡唑类黄嘌呤氧化还原酶抑制剂及制备与应用
JP2006514051A (ja) 慢性心不全の治療
EP3999504A1 (en) Polymorphic forms of (r)-4-(1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl)sulfonyl)-1-fluoroethyl)-n-(isoxazol-3-yl)piperidine-1-carboxamide
CN112055590A (zh) 用于治疗醛固酮增多症的r-法屈唑
JP2025004155A (ja) コハク酸プロドラッグ、コハク酸プロドラッグを含有する組成物、及びその使用
US6004966A (en) Use of xanthine oxidase inhibitors as anti-ischaemic agents
JP6179966B2 (ja) 二環式置換ピリミジン型ｐｄｅ−５阻害剤のプロドラッグ
EP0212647A2 (en) Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
CN100502861C (zh) 抑制钠/钙交换系统的药剂
EP2586776A1 (en) Soft cationic mitochondrial uncouplers
CN119954739B (zh) 一种化合物及其制备方法以及药物组合物和应用
KR20210046115A (ko) 니아신 유도체 및 이를 함유하는 약학 조성물
CN108774220A (zh) 用于治疗心肌缺血的化合物及其应用
US11111219B2 (en) Polysubstituted pyrimidines inhibiting the formation of prostaglandin E2, a method of production thereof and use thereof
RU2527519C2 (ru) Мягкие катионные митохондриальные разобщители
WO2015147204A1 (ja) 血管新生増殖因子を阻害する医薬組成物
US20040254228A1 (en) Treatment of chronic heart failure